Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top

Current Rheumatology Reports

Issue 12/2023

Content (8 Articles)

Systemic Lupus Erythematosus

Possible Role of Dysbiosis of the Gut Microbiome in SLE

F. Naz Cemre Kalayci, Seza Ozen

Open Access Telemedicine

Digital Approaches for Myositis

Johannes Knitza, Sebastian Kuhn, Latika Gupta

Myopathy

The Role of Environmental Factors in the Development of Idiopathic Inflammatory Myopathies: a Narrative Review

Shintaro Yamamoto, Akira Yoshida, Takahisa Gono, Masataka Kuwana

Open Access Methotrexate

Oral Versus Subcutaneous Methotrexate in Immune-Mediated Inflammatory Disorders: an Update of the Current Literature

Eva Vermeer, Renske C. F. Hebing, Maartje M. van de Meeberg, Marry Lin, Tim G. J. de Meij, Eduard A. Struys, Gerrit Jansen, Michael T. Nurmohamed, Maja Bulatović Ćalasan, Robert de Jonge

Rheumatoid Arthritis

A Review of Difficult-to-Treat Rheumatoid Arthritis: Definition, Clinical Presentation, and Management

Carly Conran, Jason Kolfenbach, Kristine Kuhn, Christopher Striebich, Larry Moreland

Rheumatoid Arthritis

How to Use Janus Kinase Inhibitors in the Treatment of Rheumatoid Arthritis? A Clinical Assessment of Risks and Benefits

Fatima K. Alduraibi, Jasvinder A. Singh

Open Access Osteoarthrosis

The Potential Role of Probiotics in the Management of Osteoarthritis Pain: Current Status and Future Prospects

Syed Obaidur Rahman, Frédérique Bariguian, Ali Mobasheri

Ankylosing Spondylitis

HLA-B*27 and Ankylosing Spondylitis: 50 Years of Insights and Discoveries

Muhammad A. Khan

Nov 23
Issue: 11/2023
Jan 24
Issue: 1/2024

Latest issues

scroll for more

use your arrow keys for more

scroll or use arrow keys for more

Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits